The Active Components of Traditional Chinese Medicines Regulate the Multi-Target Signaling Pathways of Metabolic Dysfunction-Associated Fatty Liver Disease
Drug Design, Development and Therapy · 2025-04 · Volume 19 · 2693-2715
DOI: 10.2147/dddt.s514498 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2025-04. Verfasst von Zhicong Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, People's Republic of China. Hauptthemen laut MEDLINE: Medicine, Chinese Traditional, Drugs, Chinese Herbal, Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit wurde bisher 30-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, People's Republic of China.
- Department of Cardiology, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, People's Republic of China.
- Affiliated Hospital of Shandong Academy of Traditional Chinese Medicine, Jinan City, Shandong Province, People's Republic of China.
- Scientific Research Office, Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, People's Republic of China.
ORCID-Profile: Zhicong Song
Zitieren
APA
Song, Z., Bu, S., Sang, S., Li, J., Zhang, X., Song, X., & Ran, Y. (2025). The Active Components of Traditional Chinese Medicines Regulate the Multi-Target Signaling Pathways of Metabolic Dysfunction-Associated Fatty Liver Disease. Drug Design, Development and Therapy, Volume 19, 2693-2715. https://doi.org/10.2147/dddt.s514498
Vancouver
Song Z, Bu S, Sang S, Li J, Zhang X, Song X, et al. The Active Components of Traditional Chinese Medicines Regulate the Multi-Target Signaling Pathways of Metabolic Dysfunction-Associated Fatty Liver Disease. Drug Design, Development and Therapy. 2025;Volume 19:2693-2715. doi:10.2147/dddt.s514498
BibTeX
@article{Song2025,
author = {Song, Zhicong and Bu, Shuai and Sang, Suzhen and Li, Jie and Zhang, Xihai and Song, Xu and Ran, Yuqin},
title = {The Active Components of Traditional Chinese Medicines Regulate the Multi-Target Signaling Pathways of Metabolic Dysfunction-Associated Fatty Liver Disease},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {2693--2715},
doi = {10.2147/dddt.s514498}
}
EUVIMED